About company

For almost 30 years, SPERCO has been participating in the development of Ukraine’s pharmaceutical industry by selling niche products in the segments of medicines, dietary supplements, medical devices, and cosmetics. All the company’s products, both those of its own production and those produced to order, meet international quality standards, and the medicines additionally comply with the official licensing conditions of Ukraine regarding the production, import, and wholesale trade of medicinal products.

The company SPERCO was founded shortly after Ukraine gained independence, in the distant year of 1995, as a joint Ukrainian-Spanish venture “Sperco Ukraine.” Starting from scratch with a staff of only five employees in a rented space, the company released its first self-produced pharmaceutical product onto the Ukrainian market just four years later, and subsequently, it managed to acquire state-owned production facilities in the Ukrainian city of Vinnytsia. From that moment, the company has been continuously expanding its own production, and in 2016, its production was officially certified as meeting the international requirements of Good Manufacturing Practice (GMP).

The production facilities of SPERCO are located in the Ukrainian city of Vinnytsia, a few hours’ drive from Kyiv. The manufacturing of SPERCO products takes place at new production sites using “clean room” technology, and high-tech modern equipment is involved in the production and related processes. SPERCO owns four production sites where the manufacturing of soft medicinal forms (e.g., the product “Kremgen”), liquid medicinal forms (e.g., “Noxprey”), solid medicinal forms (e.g., “Cardonat”), and secondary packaging takes place. All four sites are certified as compliant with international Good Manufacturing Practice (GMP) standards.

According to the independent analytical company Proxima Research, in 2023, SPERCO achieved significant results in the retail segment, with sales exceeding 1 billion hryvnias. SPERCO demonstrates growth both through well-known brands that occupy leading positions in their competitive niches and through brands that have entered the market relatively recently: in 2023, SPERCO introduced 7 new products into its portfolio. The company is one of the fastest-growing players in the Ukrainian pharmaceutical market.